Lung Volume Changes in Stable Preterm Infants Positioned in Car Seats
Launched by UNIVERSITY OF ZURICH · Dec 4, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the position of preterm infants in car seats affects their lung volume, which is important for safe breathing. Premature infants, those born before 37 weeks of pregnancy, are often sent home in car seats that are typically designed for full-term babies. The researchers want to find out if lying back in a car seat can lead to changes in how well these infants breathe. They will use a special technique called electrical impedance tomography, which helps measure lung volume in a safe way.
To participate in this study, infants must be born prematurely, with a gestational age of up to 36 weeks and weighing less than 2.5 kg. They should be ready to go home from the hospital within 48 hours and have consent from their parents or guardians. However, infants with serious lung problems or other severe conditions may not be eligible. Parents who join the study can expect to help the researchers understand how to keep their babies safe and healthy during car rides.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Gestational age up to 36 6/7 weeks at birth and/or birthweight \< 2.5 kg
- • Preterm born infants fulfilling all criteria for discharge from the NICU
- • Discharge home planned within 48 hours
- • Written informed consent by one or both parents or legal guardians as documented by signature.
- Exclusion Criteria:
- • Severe malformation adversely affecting lung aeration or malformations limiting life expectancy.
- • Inability of the parents to understand the study procedures due to cognitive or linguistic reasons.
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Dirk Bassler, Prof.
Study Chair
Newborn Research, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported